Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Theratechnologies Inc    TH   CA88338H1001

THERATECHNOLOGIES INC

(TH)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
05/13/2019 05/14/2019 05/15/2019 05/16/2019 05/17/2019 Date
6.22(c) 6.28(c) 6.14(c) 6.13(c) 6.05(c) Last
197 503 147 666 122 237 195 415 209 969 Volume
-6.89% +0.96% -2.23% -0.16% -1.31% Change
More quotes
Financials (CAD)
Sales 2019 119 M
EBIT 2019 29,2 M
Net income 2019 25,0 M
Debt 2019 -
Yield 2019 -
Sales 2020 196 M
EBIT 2020 55,0 M
Net income 2020 73,4 M
Debt 2020 -
Yield 2020 -
P/E ratio 2019 21,29
P/E ratio 2020 7,37
Capi. / Sales2019 3,93x
Capi. / Sales2020 2,38x
Capitalization 465 M
More Financials
Company
Theratechnologies Inc is a Canada-based specialty pharmaceutical company. The Company addresses medical needs to promote healthy living for human immunodeficiency virus (HIV) patients. Its products include EGRIFTA and Ibalizumab. EGRIFTA (tesamorelin for injection) refers to tesamorelin and it is... 
Sector
Pharmaceuticals
Calendar
05/21 | 09:00amPresentation
More about the company
Surperformance© ratings of Theratechnologies Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on THERATECHNOLOGIES INC
05/16THERATECHNOLOGIES : Positive Results From Theratechnologies' Targeted Oncology T..
AQ
05/15THERATECHNOLOGIES : Announcements in Conjunction With Theratechnologies Annual M..
AQ
05/15THERATECHNOLOGIES : CFO to Attend RBC Capital Markets Healthcare Conference in N..
AQ
05/14THERATECHNOLOGIES : rsquo; CFO to Attend RBC Capital Markets Healthcare Conferen..
AQ
04/12THERATECHNOLOGIES : Trogarzo Receives Positive Recommendation from Scientific Ad..
AQ
04/11Trogarzo® Receives Positive Recommendation from Scientific Advisory Group of..
GL
04/05THERATECHNOLOGIES : Announces Financial Results for the First Quarter of 2019
AQ
04/04THERATECHNOLOGIES : Fiscal 1Q Earnings Snapshot
AQ
04/04THERATECHNOLOGIES : Announces Financial Results for the First Quarter of 2019
AQ
04/01THERATECHNOLOGIES INC : quaterly earnings release
More news
Analyst Recommendations on THERATECHNOLOGIES INC
More recommendations
Sector news : Specialty & Advanced Pharmaceuticals
05/19Modi’s jobs deficit - J&J’s largest India plant idle three years ..
RE
05/17EXCLUSIVE : FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft ..
RE
05/17ABBVIE : halts enrollment after brain cancer trial misses goal, shares fall
RE
05/17ABBVIE : Glioblastoma Drug Misses Primary Endpoint
DJ
05/16MIRATI THERAPEUTICS : Shares Jump 17% on Rival Amgen's Progress on Potential Can..
DJ
More sector news : Specialty & Advanced Pharmaceuticals
Chart THERATECHNOLOGIES INC
Duration : Period :
Theratechnologies Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THERATECHNOLOGIES INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Average target price 12,6  CAD
Spread / Average Target 109%
EPS Revisions
Managers
NameTitle
Luc Tanguay President, Chief Executive Officer & Director
Dawn Svoronos Chairman
Philippe Dubuc Chief Financial Officer & Senior Vice President
Christian Marsolais Chief Medical Officer & Senior Vice President
Gérald A. Lacoste Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
THERATECHNOLOGIES INC-27.28%346
WUXI APPTEC CO LTD7.48%13 519
MERCK KGAA1.82%13 213
KYOWA HAKKO KIRIN CO LTD-0.59%9 881
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD25.20%9 461
JAZZ PHARMACEUTICALS PLC12.26%7 885